Another player is getting in fiscal shape to compete in the increasingly popular weight-loss device market. Baronova Inc. (Goleta, Calif.) raised $36.5 million in a series D round and said it will use the proceeds to fund a U.S. pivotal study of its Transpyloric Shuttle (TPS) device. The TPS, which can be endoscopically delivered and retrieved, is designed to slow gastric emptying as a mechanism of action for weight loss.